江蘇索普(600746.SH):上半年扭虧為盈 淨利850.20萬元
格隆匯8月25日丨江蘇索普(600746.SH)披露2020年半年度報告,報告期內,公司實現營業收入15.01億元,同比增長763.33%;歸屬於上市公司股東的淨利潤為850.20萬元,上年同期為虧損114.15萬元;歸屬於上市公司股東的扣除非經常性損益的淨利潤為568.45萬元,大幅低於公司2019年重大資產重組後的序時計劃,這主要是因為公司核心產品醋酸的市場行情在今年上半年下跌嚴重,公司上半年醋酸產品銷量及出廠價相較去年同期分別下跌17.9%和18.4%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.